<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04830644</url>
  </required_header>
  <id_info>
    <org_study_id>SIM 1910-08-Ⅱ</org_study_id>
    <nct_id>NCT04830644</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study to Evaluate the Efficacy and Safety of Iguratimod in Patients With Active Primary Sjogren's Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jiangsu Simcere Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jiangsu Simcere Pharmaceutical Co., Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of iguratimod compared to&#xD;
      placebo in patients with active primary Sjogren's Syndrome.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 22, 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI)</measure>
    <time_frame>Week 12</time_frame>
    <description>The EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) total score is calculated as the sum of scores for activity level for each domain.&#xD;
Overall score, which can range from 0 to 123, a higher score indicates more disease activity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI)</measure>
    <time_frame>Week 12</time_frame>
    <description>The total score EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI) is calculated as the mean of the 3 individual components.&#xD;
Total Score Range (0 = Best outcome and 10 = Worst Outcome)&#xD;
The scores for the ESSPRI individual components will be used as such reported by the participants and entered in the case report form (CRF), without any further calculations. It consists of 3 questions covering cardinal symptoms of Sjögren's syndrome: dryness, fatigue and pain. Each domain scored on scale of 0-10 (0 =no symptom at all and 10 = worst symptom imaginable), and overall score is calculated as the mean of 3 individual domains.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the Unstimulated Salivary Flow</measure>
    <time_frame>Week 12</time_frame>
    <description>The mean change from baseline in unstimulated whole salivary flow at all measured time points up to Week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Schirmer's Test</measure>
    <time_frame>Week 12</time_frame>
    <description>The Mean change from baseline in Schirmer's Test at all measured time points up to Week 12&#xD;
The length in millimeters that the strip wets during the 5 minute test period for each eye. Collection is done separately for each eye.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the level of immunoglobulin (IgG, IgA, IgM)</measure>
    <time_frame>Week 12</time_frame>
    <description>The change from baseline in the level of immunoglobulin (IgG, IgA, IgM) at all measured time points up to Week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the level of rheumatoid factor (RF)</measure>
    <time_frame>Week 12</time_frame>
    <description>The change from baseline in the level of RF at all measured time points up to Week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the level of B -cell activation factor (BAFF)</measure>
    <time_frame>Week 12</time_frame>
    <description>The change from baseline in the level of BAFF at all measured time points up to Week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the level of T/B/NK cell subsets</measure>
    <time_frame>Week 12</time_frame>
    <description>The change from baseline in the level of T/B/NK cell subsets at all measured time points up to Week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the level of erythrocyte sedimentation rate (ESR)</measure>
    <time_frame>Week 12</time_frame>
    <description>The change from baseline in the level of ESR at all measured time points up to Week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the level of serum complement (C3 and C4)</measure>
    <time_frame>Week 12</time_frame>
    <description>The change from baseline in the level of serum complement (C3 and C4) at all measured time points up to Week 12</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Primary Sjögren Syndrome</condition>
  <arm_group>
    <arm_group_label>Iguratimod 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>orally 25mg twice a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Iguratimod 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>orally 20mg twice a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Iguratimod 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>orally 10mg twice a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>orally twice a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iguratimod</intervention_name>
    <description>Iguratimod orally twice a day</description>
    <arm_group_label>Iguratimod 1</arm_group_label>
    <arm_group_label>Iguratimod 2</arm_group_label>
    <arm_group_label>Iguratimod 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo orally twice a day</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  meet the 2016 American College of Rheumatology (ACR) / European League Against&#xD;
             Rheumatism Classification Criteria for Sjogren's Syndrome (EULAR SS)&#xD;
&#xD;
          -  ESSDAI score ≥6&#xD;
&#xD;
          -  IgG &gt;16 g/L&#xD;
&#xD;
          -  Positive anti-SS-A/Ro antibody at screening&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or breast feeding&#xD;
&#xD;
          -  Secondary Sjogren's syndrome&#xD;
&#xD;
          -  severe renal or haematological failure, a history of cancer, hepatitis B or C, human&#xD;
             immunodeficiency virus, severe diabetes or any other chronic disease or evidence of&#xD;
             infection&#xD;
&#xD;
          -  Prior administration of any of the following:&#xD;
&#xD;
               1. Rituximab in the past 12 months prior to randomization;&#xD;
&#xD;
               2. Cyclophosphamide, mycophenolate mofetil, methotrexate, leflunomide and iguratimod&#xD;
                  in the past 12 weeks prior to randomization;&#xD;
&#xD;
               3. Azathioprine, cyclosporin, tacrolimus, sirolimus, sulfasalazine in the past 4&#xD;
                  weeks prior to randomization;&#xD;
&#xD;
               4. live vaccine in the past 12 weeks prior to randomization&#xD;
&#xD;
          -  Corticosteroids: &gt; 10 mg/day oral prednisone (or equivalent); Any change or initiation&#xD;
             of new dose within 4 weeks prior to randomization; Intramuscular, subcutaneous,&#xD;
             intravenous, or intra-articular corticosteroids within 4 weeks prior to randomization.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lai Zhiqiang</last_name>
    <phone>+86-18697190725</phone>
    <email>laizhiqiang@simcere.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhanguo Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Xiamen University</name>
      <address>
        <city>Xiamen</city>
        <state>Fujian</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guixiu Shi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southern Medical University Nanfang Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min Yang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sun Yat-sen Memorial Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yingqian Mo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>the Second Affiliated Hospital of Guangxi Medical University</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Meiling li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hebei General Hospital</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fengxiao Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>the Second Hospital of HeBei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongtao Jin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>the First Affiliated Hospital of Henan University of Science and Technology</name>
      <address>
        <city>Luoyang</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaofei Shi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Xinxiang Central Hospital</name>
      <address>
        <city>Xinxiang</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wenqiang Fan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shengyun Liu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fen Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospitalof Inner Mongolia Medical University</name>
      <address>
        <city>Hohhot</city>
        <state>Inner Mongolia</state>
        <zip>010000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ning Tie</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jiangsu Province Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lei Gu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nanjing Drum Tower Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lingyun Sun</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jilin Province People's Hospital</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lin Chen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>the First Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhenyu Jiang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shandong Provincial Hospital Affliated to Shandong First Medical University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongsheng Sun</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Qilu Hospital of Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Huaxiang Liu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>the Shanghai Ninth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Futao Zhao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital of Tongji University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jianping Tang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Heping Hospital Affiliated to Changzhi Medical College</name>
      <address>
        <city>Changzhi</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huiping Gong</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanxi Bethune hospital</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Liyun Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>the Second Hospital of Shanxi Medical University</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaoxia Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>the Second Affiliated Hospital of Xi'an Jiaotong University</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xueyi Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tianjin First Central Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wufang Qi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhejiang Provincial People's Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yasong Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Jiaxing University</name>
      <address>
        <city>Jiaxing</city>
        <state>Zhejiang</state>
        <zip>314000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiao Ye</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ningbo First Hospital</name>
      <address>
        <city>Ningbo</city>
        <state>Zhejiang</state>
        <zip>315010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiudi Wu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>the First People's Hospital of Wenling</name>
      <address>
        <city>Wenling</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yongjun Cheng</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Wenzhou Medical University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li Sun</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 28, 2021</study_first_submitted>
  <study_first_submitted_qc>April 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2021</study_first_posted>
  <last_update_submitted>July 16, 2021</last_update_submitted>
  <last_update_submitted_qc>July 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

